Exosome MS4A8 Drives Prostate Cancer Bone Metastasis via RANKL Signaling Pathways
Researchers have identified that exosome MS4A8 promotes prostate cancer bone metastasis and osteolytic destruction by activating NF-κB and AKT pathways ...
Researchers have identified that exosome MS4A8 promotes prostate cancer bone metastasis and osteolytic destruction by activating NF-κB and AKT pathways ...
Combining bortezomib and riluzole synergistically inhibited cell growth, migration, and stemness markers in laboratory models of human castration-resistant prostate cancer.
A retrospective study shows PSMA PET/MRI provides superior lymph node staging sensitivity over mpMRI in intermediate- and high-risk prostate cancer, ...
A comprehensive literature review reveals that robot-assisted radical prostatectomy enhances early continence and potency recovery compared to conventional laparoscopy, though ...
A real-world study of 125 men demonstrates that the three-tier STRATCANS active surveillance protocol safely manages early prostate cancer with ...
Researchers found that COMP interacts directly with MUC1 to confer ferroptosis resistance and drive prostate cancer bone metastasis.
An international study of 1758 men with non-metastatic prostate cancer found that pre-radiotherapy fatigue and diabetes were the strongest predictors ...
Researchers developed PL051, a syngeneic mouse prostate cancer cell line that is androgen-dependent, metastatic and immunocompetent, enabling tests of combined ...
A GLOBOCAN 2022 analysis of 185 countries shows that lifetime risk of penile, prostate, and testicular cancers is highest in ...
A scientific review details the clinical momentum, biological complexity, and dosimetric challenges shaping the next era of precision radiopharmaceutical cancer ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine